Thalassemia Patients and Friends
Discussion Forums => Iron Chelation Corner => Topic started by: Andy Battaglia on March 31, 2015, 03:01:19 AM
-
The advantages to this form of Exjade are that it is a once a day, time release, oral pill. Because the drug is released slowly, it should be a little easier on the digestive system, compared to taking a whole immediately acting dose. This will also give patients a longer chelation period than with the tabs, which have a half life of 8-16 hours. This should result in better chelation.
http://www.multivu.com/players/English/7440151-novartis-jadenu-fda-approval/
Novartis announces FDA approval for Jadenu™ to simplify treatment administration for patients with chronic iron overload
Jadenu (deferasirox), a new formulation of Exjade (deferasirox), is the only once-daily oral film-coated tablet for iron chelation
Jadenu, taken with or without food, simplifies daily treatment administration for patients with chronic iron overload
Chronic iron overload is a serious condition that can affect people with sickle cell disease, thalassemia and myelodysplastic syndromes
-
Its Great.
Thanks Andy, for sharing the news.
Regards,
AshutoshT
-
Andy,
Thanks for the posting. This will make it even easier for patients that are already doing well on Exjade but hates the chalky taste. Every day thalasemmia management is getting easier. Thank God!
-
Thanks Andy for sharing.
When the day will come then no need transfusion for thalassemia patients, only oral tablet or capsule will solve the problem..When??
When ???
-
Thank you for sharing Andy. Lil A is excited about this pill - he is good about taking his exjade but would prefer not to drink the chalky liquid.
-
Andy,
what is the difference between the 2 pills jadenu and ferriprox?
-
Jadenu = Exjade
Just in a new form. Pills you can swallow and don't need to solve in water...
In Germany there will be available approximately in the end of 2016. I think so it will be for France.